| Literature DB >> 16616019 |
Alberto Dominguez-Rodriguez1, Pedro Abreu-Gonzalez, Martín Garcia-Gonzalez, Russel J Reiter.
Abstract
We evaluated the possible relation between circulating levels of nocturnal melatonin, C-reactive protein, and the development of adverse cardiovascular events in patients with ST-segment elevation myocardial infarction. Patients who had developed adverse events during follow-up had significantly lower nocturnal melatonin levels than patients without events.Entities:
Mesh：
Substances：
Year: 2006 PMID： 16616019 DOI： 10.1016/j.amjcard.2005.11.033
Source DB: PubMed Journal: Am J Cardiol ISSN： 0002-9149 Impact factor: 2.778